Inflammation métabolique et insulino-résistance : Les connaissances actuelles

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Médecine des Maladies Métaboliques

• Publication date

  2015-05-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/S1957-2557(15)30075-4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-6, soluble interleukin-6 receptor/interleukin-6 complex and insulin resistance in obese children and adolescents

  2015cited by this paper
• Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans

  2014cited by this paper
• Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis.

  2014cited by this paper
• Role of adiponectin system in insulin resistance.

  2014cited by this paper
• Targeting inflammation in the treatment of type 2 diabetes: time to start

  2014cited by this paper
• Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.

  2014cited by this paper
• A Molecular Web: Endoplasmic Reticulum Stress, Inflammation, and Oxidative Stress

  2014cited by this paper
• LPA receptor signaling: pharmacology, physiology, and pathophysiology

  2014cited by this paper
• Interferon regulatory factor 3 constrains IKKβ/NF‐κB signaling to alleviate hepatic steatosis and insulin resistance

  2014cited by this paper
• Chaperoning to the metabolic party: The emerging therapeutic role of heat-shock proteins in obesity and type 2 diabetes

  2014cited by this paper
• Branched-chain amino acids in metabolic signalling and insulin resistance

  2014cited by this paper
• A Gpr120 Selective Agonist Improves Insulin Resistance and Chronic Inflammation

  2014cited by this paper
• IκB kinase ɛ (IKKɛ): A therapeutic target in inflammation and cancer

  2013cited by this paper
• Monocyte Chemoattractant Protein-1 Deficiency Attenuates Oxidative Stress and Protects against Ovariectomy-Induced Chronic Inflammation in Mice

  2013cited by this paper
• An inhibitor of the protein kinases TBK1/IKKε improves obesity-related metabolic dysfunctions

  2013cited by this paper
• The interleukin-1 family: back to the future.

  2013cited by this paper
• Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages

  2013cited by this paper
• Interleukin-18 Activates Skeletal Muscle AMPK and Reduces Weight Gain and Insulin Resistance in Mice

  2013cited by this paper
• Targeting Sirtuin 1 to Improve Metabolism: All You Need Is NAD+?

  2012cited by this paper
• Revisiting the diacylglycerol‐induced insulin resistance hypothesis

  2012cited by this paper
• A ceramide-centric view of insulin resistance.

  2012cited by this paper
• Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling.

  2012cited by this paper
• Dietary fatty acids in metabolic syndrome, diabetes and cardiovascular diseases.

  2012cited by this paper
• Inflammation links excess fat to insulin resistance: the role of the interleukin‐1 family

  2012cited by this paper
• Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human

  2012cited by this paper
• Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice

  2012cited by this paper
• Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

  2012cited by this paper
• Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis

  2011cited by this paper
• Inflammatory links between obesity and metabolic disease.

  2011cited by this paper
• AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan

  2011cited by this paper
• Protein kinase C isoforms: Mediators of reactive lipid metabolites in the development of insulin resistance

  2011cited by this paper
• Pathogenic Role of Scavenger Receptor CD36 in the Metabolic Syndrome and Diabetes

  2011cited by this paper
• Regulation of adiponectin production by insulin: interactions with tumor necrosis factor-α and interleukin-6.

  2011cited by this paper
• Inflammatory mechanisms in obesity.

  2011cited by this paper
• Alternative macrophage activation and metabolism.

  2011cited by this paper
• Toll-like receptors: linking inflammation to metabolism.

  2011cited by this paper
• JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction

  2010cited by this paper
• An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice.

  2010cited by this paper
• Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.

  2010cited by this paper
• Natural Killer T Cells Are Involved in Adipose Tissues Inflammation and Glucose Intolerance in Diet-Induced Obese Mice

  2010cited by this paper
• GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects.

  2010cited by this paper
• Irs1 serine 307 promotes insulin sensitivity in mice.

  2010cited by this paper
• Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis.

  2010cited by this paper
• Mechanisms of TNF-alpha-induced insulin resistance.

  2009cited by this paper
• The protein kinase IKKepsilon regulates energy balance in obese mice.

  2009cited by this paper
• Hypoxia-Inducible Factor 1α Induces Fibrosis and Insulin Resistance in White Adipose Tissue

  2009cited by this paper
• Palmitate Induces Insulin Resistance in H4IIEC3 Hepatocytes through Reactive Oxygen Species Produced by Mitochondria

  2009cited by this paper
• Deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice

  2009cited by this paper
• Association of variation in the interleukin-1 gene family with diabetes and glucose homeostasis.

  2009cited by this paper
• Interplay Between Human Adipocytes and T Lymphocytes in Obesity: CCL20 as an Adipochemokine and T Lymphocytes as Lipogenic Modulators

  2009cited by this paper
• TANK-binding kinase 1 mediates phosphorylation of insulin receptor at serine residue 994: a potential link between inflammation and insulin resistance.

  2009cited by this paper
• Mechanisms of obesity and related pathologies: The macro‐ and microcirculation of adipose tissue

  2009cited by this paper
• Normalization of Obesity-Associated Insulin Resistance through Immunotherapy: CD4+ T Cells Control Glucose Homeostasis

  2009cited by this paper
• CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity

  2009cited by this paper
• Mechanisms of macrophage activation in obesity-induced insulin resistance

  2008cited by this paper
• Protein-tyrosine Phosphatase 1B Expression Is Induced by Inflammation in Vivo*

  2008cited by this paper
• Dual Role of Interleukin-6 in Regulating Insulin Sensitivity in Murine Skeletal Muscle

  2008cited by this paper
• Insulin sensitivity: modulation by nutrients and inflammation.

  2008cited by this paper
• Exploring the full spectrum of macrophage activation

  2008cited by this paper
• CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity.

  2008cited by this paper
• When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction.

  2008cited by this paper
• Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity.

  2008cited by this paper
• Association of serum MCP-1 concentration and MCP-1 polymorphism with insulin resistance in Japanese individuals with obese type 2 diabetes.

  2007cited by this paper
• Monocyte chemotactic protein-1 and its role in insulin resistance

  2007cited by this paper
• Proinflammatory Cytokines in Obesity: Impact of Type 2 Diabetes Mellitus and Gastric Bypass

  2007cited by this paper
• Macrophage-specific PPARγ controls alternative activation and improves insulin resistance

  2007cited by this paper
• Metabolic stress signaling mediated by mixed-lineage kinases.

  2007cited by this paper
• Obesity induces a phenotypic switch in adipose tissue macrophage polarization.

  2007cited by this paper
• Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones.

  2007cited by this paper
• Adipocytes as regulators of energy balance and glucose homeostasis

  2006cited by this paper
• The unfolded protein response

  2006cited by this paper
• Adipocytokines: mediators linking adipose tissue, inflammation and immunity

  2006cited by this paper
• Interleukin-1α inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes

  2006cited by this paper
• Activation of endoplasmic reticulum stress response during the development of ischemic heart disease.

  2006cited by this paper
• Toll-like Receptor-2 Is Essential for the Development of Palmitate-induced Insulin Resistance in Myotubes*

  2006cited by this paper
• TLR4 links innate immunity and fatty acid-induced insulin resistance.

  2006cited by this paper
• Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation.

  2006cited by this paper
• Adipose tissues as an ancestral immune organ: Site‐specific change in obesity

  2005cited by this paper
• Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.

  2003cited by this paper
• Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects*

  2003cited by this paper
• Signalling pathways of the TNF superfamily: a double-edged sword

  2003cited by this paper
• Interleukin-6 induces cellular insulin resistance in hepatocytes.

  2002cited by this paper
• Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptors

  2002cited by this paper
• Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance.

  2002cited by this paper
• A central role for JNK in obesity and insulin resistance

  2002cited by this paper
• Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.

  2001cited by this paper
• Tumor Necrosis Factor α-Mediated Insulin Resistance, but Not Dedifferentiation, Is Abrogated by MEK1/2 Inhibitors in 3T3-L1 Adipocytes

  2000cited by this paper
• Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus

  1999cited by this paper
• Cytokines and the hepatic acute phase response

  1997cited by this paper
• NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

  1997cited by this paper
• Cloning of a new cytokine that induces IFN-γ production by T cells

  1995cited by this paper
• Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.

  1995cited by this paper
• Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

  1993cited by this paper
• Salicylates as Hypoglycemic Agents

  1982cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Hormone Replacement Therapy and Interrelation between Serum Interleukin-6 and Body Mass Index in Postmenopausal Women: A Population-Based Study

  year unknowncited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo*

  year unknowncited by this paper

• Variabilité de la triglycéridémie : impact métabolique. De la dysfonction du tissu adipeux à l’adiposité viscérale et à la stéatopathie métabolique, les chemins de l’insulino-résistance

  2022cites this paper